These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 17096153)

  • 21. Engineered IgG1-Fc Molecules Define Valency Control of Cell Surface Fcγ Receptor Inhibition and Activation in Endosomes.
    Bailey EM; Choudhury A; Vuppula H; Ortiz DF; Schaeck J; Manning AM; Bosques CJ; Hoppe AD
    Front Immunol; 2020; 11():617767. PubMed ID: 33679705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acidic pH increases the avidity of FcgammaR for immune complexes.
    López DH; Trevani AS; Salamone G; Andonegui G; Raiden S; Giordano M; Geffner JR
    Immunology; 1999 Nov; 98(3):450-5. PubMed ID: 10583607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Harnessing the immune system via FcγR function in immune therapy: a pathway to next-gen mAbs.
    Chenoweth AM; Wines BD; Anania JC; Mark Hogarth P
    Immunol Cell Biol; 2020 Apr; 98(4):287-304. PubMed ID: 32157732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor immune effector mechanisms recruited by phage display-derived fully human IgG1 and IgA1 monoclonal antibodies.
    Huls G; Heijnen IA; Cuomo E; van der Linden J; Boel E; van de Winkel JG; Logtenberg T
    Cancer Res; 1999 Nov; 59(22):5778-84. PubMed ID: 10582699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunotherapy targeting inhibitory Fcγ receptor IIB (CD32b) in the mouse is limited by monoclonal antibody consumption and receptor internalization.
    Williams EL; Tutt AL; Beers SA; French RR; Chan CH; Cox KL; Roghanian A; Penfold CA; Butts CL; Boross P; Verbeek JS; Cragg MS; Glennie MJ
    J Immunol; 2013 Oct; 191(8):4130-40. PubMed ID: 24026082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The function of Fcγ receptors in dendritic cells and macrophages.
    Guilliams M; Bruhns P; Saeys Y; Hammad H; Lambrecht BN
    Nat Rev Immunol; 2014 Feb; 14(2):94-108. PubMed ID: 24445665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Cell-Based Reporter Assay Measuring the Activation of Fc Gamma Receptors Induced by Therapeutic Monoclonal Antibodies.
    Aoyama M; Tada M; Ishii-Watabe A
    Methods Mol Biol; 2019; 1904():423-429. PubMed ID: 30539484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Murine Fc receptors for IgG are redundant in facilitating presentation of immune complex derived antigen to CD8+ T cells in vivo.
    de Jong JM; Schuurhuis DH; Ioan-Facsinay A; van der Voort EI; Huizinga TW; Ossendorp F; Toes RE; Verbeek JS
    Mol Immunol; 2006 May; 43(13):2045-50. PubMed ID: 16513171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory FcγRIIb-Mediated Soluble Antigen Clearance from Plasma by a pH-Dependent Antigen-Binding Antibody and Its Enhancement by Fc Engineering.
    Iwayanagi Y; Igawa T; Maeda A; Haraya K; Wada NA; Shibahara N; Ohmine K; Nambu T; Nakamura G; Mimoto F; Katada H; Ito S; Tachibana T; Jishage K; Hattori K
    J Immunol; 2015 Oct; 195(7):3198-205. PubMed ID: 26320252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding.
    Borrok MJ; Luheshi NM; Beyaz N; Davies GC; Legg JW; Wu H; Dall'Acqua WF; Tsui P
    MAbs; 2015; 7(4):743-51. PubMed ID: 25970007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity.
    Quast I; Keller CW; Maurer MA; Giddens JP; Tackenberg B; Wang LX; Münz C; Nimmerjahn F; Dalakas MC; Lünemann JD
    J Clin Invest; 2015 Nov; 125(11):4160-70. PubMed ID: 26436649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The FcγR of humans and non-human primates and their interaction with IgG: implications for induction of inflammation, resistance to infection and the use of therapeutic monoclonal antibodies.
    Hogarth PM; Anania JC; Wines BD
    Curr Top Microbiol Immunol; 2014; 382():321-52. PubMed ID: 25116107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction sites on human IgG-Fc for FcgammaR: current models.
    Jefferis R; Lund J
    Immunol Lett; 2002 Jun; 82(1-2):57-65. PubMed ID: 12008035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory Fcγ receptor engagement drives adjuvant and anti-tumor activities of agonistic CD40 antibodies.
    Li F; Ravetch JV
    Science; 2011 Aug; 333(6045):1030-4. PubMed ID: 21852502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Field flow fractionation for assessing neonatal Fc receptor and Fcγ receptor binding to monoclonal antibodies in solution.
    Pollastrini J; Dillon TM; Bondarenko P; Chou RY
    Anal Biochem; 2011 Jul; 414(1):88-98. PubMed ID: 21385563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infliximab treatment shifts the balance between stimulatory and inhibitory Fcgamma receptor type II isoforms on neutrophils in patients with rheumatoid arthritis.
    Belostocki K; Pricop L; Redecha PB; Aydin A; Leff L; Harrison MJ; Salmon JE
    Arthritis Rheum; 2008 Feb; 58(2):384-8. PubMed ID: 18240208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgG subclasses determine pathways of anaphylaxis in mice.
    Beutier H; Gillis CM; Iannascoli B; Godon O; England P; Sibilano R; Reber LL; Galli SJ; Cragg MS; Van Rooijen N; Mancardi DA; Bruhns P; Jönsson F
    J Allergy Clin Immunol; 2017 Jan; 139(1):269-280.e7. PubMed ID: 27246523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-retroviral antibody FcγR-mediated effector functions.
    Bournazos S; Ravetch JV
    Immunol Rev; 2017 Jan; 275(1):285-295. PubMed ID: 28133801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulated expression of FcgammaR in human dendritic cells controls cross-presentation of antigen-antibody complexes.
    Liu Y; Gao X; Masuda E; Redecha PB; Blank MC; Pricop L
    J Immunol; 2006 Dec; 177(12):8440-7. PubMed ID: 17142741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FcγRΙΙB controls the potency of agonistic anti-TNFR mAbs.
    White AL; Chan HT; French RR; Beers SA; Cragg MS; Johnson PW; Glennie MJ
    Cancer Immunol Immunother; 2013 May; 62(5):941-8. PubMed ID: 23543215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.